- Home
- WHWK vs FOA Comparison
WHWK vs FOA Comparison
Compare WHWK & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHWK | FOA |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 221.6M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WHWK | FOA |
|---|---|---|
| Price | $4.73 | $20.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.50 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 431.8K | 41.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.02 | ★ 216.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | $7,145,000.00 | ★ $497,432,000.00 |
| Revenue This Year | N/A | $0.58 |
| Revenue Next Year | N/A | $6.91 |
| P/E Ratio | ★ N/A | $51.44 |
| Revenue Growth | N/A | ★ 47.09 |
| 52 Week Low | $1.60 | $15.77 |
| 52 Week High | $5.50 | $29.79 |
Technical Indicators
Market Signals| Indicator | WHWK | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | 38.13 |
| Support Level | $3.79 | $18.65 |
| Resistance Level | $4.84 | $24.03 |
| Average True Range (ATR) | 0.29 | 1.04 |
| MACD | 0.06 | -0.21 |
| Stochastic Oscillator | 86.80 | 1.87 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About FOA Finance of America Companies Inc.
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.